Awarded vendors
- Aura Staffing Partners Chicago, LLC
Description
This contract establishes a master agreement for the Commonwealth of Massachusetts to secure qualified health‑care providers that can augment public‑health capacity. The agreement covers three service areas: (1) therapeutic administration of FDA‑approved or EUA‑authorized COVID‑19 treatments, (2) deployment of rapid‑response medical teams (7‑, 14‑, or 35‑person configurations) for disaster or surge events, and (3) management and coordination of a broad range of nursing, medical, and ancillary support services across multiple facilities. Vendors submit a single application via COMMBUYS, provide a “maximum daily rate” for their highest‑paid professional, and may request pre‑approved one‑time start‑up costs (e.g., mobile unit lease, infusion equipment). The contract runs for ten years (2022‑2032) with an optional five‑year renewal, has an estimated total value of roughly $60 million, and includes a supplier‑diversity scoring component (25 % of overall score). The only vendor identified for award at this stage is Aura Staffing Partners Chicago, LLC.
• Therapeutic services: outpatient administration of antivirals and monoclonal antibodies (e.g., PAXLOVID®, EVUSHELD®, bebtelovimab).
• Deployable Medical Teams: hospital‑based teams ready for mass‑casualty, alternate‑care‑site, and staffing‑support missions.
• Management & Coordination: oversight of nursing, medical, and ancillary support functions, including facility operations and logistics.
• Pricing model: daily‑rate based on the highest‑paid professional plus separately reimbursable, pre‑approved start‑up costs.
• Procurement method: rolling IDIQ master agreement via COMMBUYS with a 10‑year base term and one optional 5‑year renewal.